Strategies to optimize the use of erythropoietin and iron therapy in oncology patients

被引:5
|
作者
Ford, PA
Mastoris, J
机构
[1] Penn Hosp, Stem Cell Transplant Program, Philadelphia, PA 19106 USA
[2] Penn Hosp, Ctr Bloodless Med & Surg, Philadelphia, PA 19106 USA
关键词
D O I
10.1111/j.0041-1132.2004.04169.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:15S / 25S
页数:11
相关论文
共 50 条
  • [31] Discussing complementary therapy use with Australian oncology patients
    Schofield, PE
    Juraskova, I
    Butow, PN
    PSYCHO-ONCOLOGY, 2003, 12 (04) : S115 - S115
  • [32] Intravenous iron reduces erythropoietin use and improves iron indices in hemodialysis patients with functional iron deficiency.
    Mulay, A
    Nadler, S
    Burns, K
    Zimmerman, D
    Knoll, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 706A - 706A
  • [33] Update on novel strategies to optimize cetuximab therapy in patients with metastatic colorectal cancer
    Macarulla, Teresa
    Javier Ramos, Francisco
    Elez, Elena
    Capdevila, Jaume
    Peralta, Sergio
    Tabernero, Josep
    CLINICAL COLORECTAL CANCER, 2008, 7 (05) : 300 - 308
  • [34] Iron overload in renal failure patients: Changes since the introduction of erythropoietin therapy
    Eschbach, JW
    Adamson, JW
    KIDNEY INTERNATIONAL, 1999, 55 : S35 - S43
  • [35] EFFICACY OF ORAL IRON THERAPY IN PATIENTS RECEIVING RECOMBINANT-HUMAN-ERYTHROPOIETIN
    WINGARD, RL
    PARKER, RA
    ISMAIL, N
    HAKIM, RM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) : 433 - 439
  • [36] Intravenous iron and erythropoietin therapy for postoperative anemia among orthopedic surgery patients
    Huixin Chen
    Jing Yu
    Qing Wei
    Yu Zhang
    Xilin Ouyang
    Shun Wang
    Journal of Orthopaedic Surgery and Research, 18
  • [37] Intravenous iron and erythropoietin therapy for postoperative anemia among orthopedic surgery patients
    Chen, Huixin
    Yu, Jing
    Wei, Qing
    Zhang, Yu
    Ouyang, Xilin
    Wang, Shun
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2023, 18 (01)
  • [38] Nomogram for individualizing supplementary iron doses during erythropoietin therapy in haemodialysis patients
    Kadota, K
    Kamata, K
    Kobayashi, Y
    Kagaya, H
    Shimada, S
    Yoshimoto-Furuie, K
    Echizen, H
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2002, 27 (02) : 111 - 119
  • [39] Communication strategies to optimize commitments and investments in iron programming
    Griffiths, M
    JOURNAL OF NUTRITION, 2002, 132 (04): : 834S - 838S
  • [40] IRON-METABOLISM AND IRON SUBSTITUTION DURING ERYTHROPOIETIN THERAPY
    SUNDERPLASSMANN, G
    HORL, WH
    CLINICAL INVESTIGATOR, 1994, 72 (06): : S11 - S15